Condition: Osteoporosis, Osteopenia · Sponsor: Promedius Inc
The goal of this study is to assess the performance of an artificial intelligence software (Osteo Signal) in detecting osteoporosis risk in adults 50 years and older. The main question it aims to answer is: What is the accuracy of the software in detecting osteoporosis risk on chest x-ray images as compared to the standard technique of dual-energy x-ray absorptiometry (DXA)? There is no direct involvement of participants in this study as it will use data from individuals who have already had a chest x-ray and a DXA scan taken in the past.
This description comes directly from the study's public registry record.
Kim Bensalem · +447885369062 · kim@medilife.net
Jung Jinho · +82 1083113509 · jhjung@promedius.ai
Always discuss trial participation with your own doctor first.
| Erasmus University Medical Center Rotterdam, | Rotterdam, Netherlands | Not Yet Recruiting |
| Mid and South Essex NHS Foundation Trust | Westcliff-on-Sea, Essex, United Kingdom | Not Yet Recruiting |
| Barts Health NHS Trust | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07421713